High-sensitivity C-reactive protein and white blood cell count equally predict development of the metabolic syndrome in a Japanese health screening population

Acta Diabetologica

Volumn 50, Issue 4, 2013, Pages 633-638

  Oda, Eiji ^a  

^a Tachikawa Medical Center   (Japan)

Author keywords

High sensitivity CRP; Inflammation; Metabolic syndrome; Obesity; White blood cell count

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; JAPANESE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL HISTORY; METABOLIC SYNDROME X; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; C-REACTIVE PROTEIN; FEMALE; HUMANS; JAPAN; LEUKOCYTE COUNT; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; ROC CURVE;

EID: 84884910550     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0477-7     Document Type: Article

References (23)

1. Oda E (2012) Metabolic syndrome: its history, mechanisms, and limitations. Acta Diabetol 49:89-95
2. World Health Organization (1999) Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO Consultation. World Health Org, Geneva
3. Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285:2486-2497
4. Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 223:469-480
5. Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752 (Pubitemid 41532612)
6. Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645
7. Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289-2304 (Pubitemid 41242486)
8. Simmons RK, Alberti KG, Gale EA et al (2010) The metabolic syndrome: useful concept or clinical tool? Report of a WHO expert consultation. Diabetologia 53:600-605
9. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808 (Pubitemid 38063703)
10. Cinti S, Mitchell G, Barbatelli G et al (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46:2347-2355 (Pubitemid 41532523)
11. Kim J, Montagnani M, Koh KK, Quon MJ (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms. Circulation 113:1888-1904 (Pubitemid 43739401)
12. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91 (Pubitemid 23036092)
13. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448-1454 (Pubitemid 40396812)
14. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695 (Pubitemid 40530235)
15. Ridker PM, Wilson PWF, Grandy SM (2004) Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109:2818-2825 (Pubitemid 38780294)
16. Tamakoshi K, Toyoshima H, Yatsuya H et al (2007) White blood cell count and risk of all-cause and cardiovascular mortality in nationwide sample of Japanese. Results from NIPPON DATA90. Circ J 71:479-485 (Pubitemid 46513452)
17. Fadini GP, Marcuzzo G, Marescotti MC, de Kreutzenberg SV, Avogaro A (2012) Elevated white blood cell count is associated with prevalence and development of the metabolic syndrome and its components in the general population. Acta Diabetol 49:445-451
18. Oda E, Kawai R (2010) Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese. Intern Med 49:117-124
19. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595-1607 (Pubitemid 19004941)
20. Nagasawa N, Tamakoshi K, Yatsuya H et al (2004) Association of white blood cell count and clustered components of metabolic syndrome in Japanese men. Circ J 68:892-897 (Pubitemid 39410212)
21. Jung CH, Lee WY, Kim SY et al (2008) The risk of metabolic syndrome according to the high-sensitivity C-reactive protein in apparently healthy Koreans. Int J Cardiol 129:266-271
22. Margolis KL, Manson JE, Greenland P et al (2005) Women's Health Initiative Research Group: leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women - the Women's Health Initiative Observational Study. Arch Intern Med 165:500-508 (Pubitemid 40344380)
23. Oda E, Kawai R (2009) Very low levels of high-sensitivity C-reactive protein are not bimodaly distributed but significantly related with other metabolic risk factors in Japanese. Intern Med 48:953-958